Charmacy Pharmaceutical Co., Ltd.

HKEX:2289.HK

9.3 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Operating Activities:
Net Income 26.74724.99226.35369.83320.639-2.80825.9619.68330.873-2.15142.305-0.20745.641.84142.91919.69636.7631.12525.2349.99626.4499.111
Depreciation & Amortization 17.62715.04811.99715.31515.36316.87315.16213.23311.3212.82711.1129.9548.4877.3516.7715.9645.5144.5714.4114.7354.992.985
Deferred Income Tax 00000000000000177.0390000000
Stock Based Compensation 000000000000000.9890000000
Change In Working Capital -3,698.857-187.183-104.34-9.351-290.859180.004-159.063-273.24145.388-176.347132.508-30.03836.255-60.333-178.028-78.087-59.15-234.2680-28.719-105.889-21.363
Accounts Receivables -3,674.663-133.53935.36518.488-240.95598.923-153.734-205.44947.42-127.577126.76-41.70289.049-80.157-77.606-76.886-28.502-160.8660-68.161-77.3140
Change In Inventory -24.194-53.644-139.706-27.839-49.90481.081-5.329-67.791-2.032-48.775.74711.664-52.79319.824-100.422-1.201-30.648-73.402039.442-28.5752.717
Change In Accounts Payables 0000000000000000000-53.30124.080
Other Working Capital 000000000000000000000-24.08
Other Non Cash Items 3,479.796279.385-162.79-0.306223.416-103.818.137601.083-307.262180.264-196.498114.48-135.4259.0586.48-36.7544.503287.863104.734-1.16174.7735.56
Operating Cash Flow -174.687132.242-228.7875.491-31.44190.259-109.802350.758-219.68114.593-10.57494.189-45.0387.909-40.869-89.181-12.3759.291134.379-15.1490.323-3.707
Investing Activities:
Investments In Property Plant And Equipment -9.879-10.671-30.177-6.128-2.46-3.354-21.685-24.348-27.634-47.262-26.641-49.853-47.873-111.17-14.456-7.673-11.902-1.656-0.497-1.275-3.172-1.112
Acquisitions Net 0000000-1.856-10000000000000
Purchases Of Investments 0000000000000000000000
Sales Maturities Of Investments 0000000000000000000000
Other Investing Activites 0.0590.12580.06180.0540.2980.6310.0070.0250.0340.0510.1090.0520.1060.0162.248-2.0432.081-98.379-67.33821.77523.5751.112
Investing Cash Flow -9.82-10.54649.88473.925-2.163-2.724-21.678-26.18-28.6-47.211-26.533-49.802-47.768-111.154-12.208-9.716-9.821-100.035-67.83520.520.4038.872
Financing Activities:
Debt Repayment 0000002.2160118.76305204.7000000000
Common Stock Issued 0000000000000000000000
Common Stock Repurchased 0000000000000000000000
Dividends Paid -14.927-63.524-11.977-13.753-14.687-27.52-24.974-29.564-26.948-42.436-19.138-15.467-32.893-27.453-23.632-37.1020-16-30000
Other Financing Activities 217.082-38.155214.918-134.801-27.9749.04175.637-242.391177.46480.319-16.617-20.56593.385108.98355.719119.163-2.469187.671-34.1385.467-26.009-65.64
Financing Cash Flow 202.156-101.679202.941-148.555-42.65721.52152.88-271.955269.27837.88216.244-36.03265.19281.53132.08882.061-2.469171.671-64.1385.467-26.009-65.64
Other Information:
Effect Of Forex Changes On Cash 0.003-0.0070.0130.0170.017-0.2410.241-0.0070.0080.0070.0020.015-0.115-0.08-1.6885.926155.629-155.62922.29673.30861.85861.858
Net Change In Cash 130.581024.0570.879-76.244108.816-78.3652.61621.0055.271-20.8618.37-27.729-21.795-22.677-10.91130.969-24.70224.70227.4297.2881.384
Cash At End Of Period 130.58192.91992.91973.73172.852144.22735.411113.77161.15540.14934.87855.73947.36875.09796.892120.059130.969024.70238.90711.4785.574